Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
sirolimus serine/threonine-protein kinase mtor small molecule Successful target TTD , drugbank , DGIDB Perivascular Epithelioid Cell Neoplasms[MeSHID:D054973]
Lymphangioleiomyomatosis[MeSHID:D018192]
Maintenance[MeSHID:D008283]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 0.17 approved,investigational inhibitor
sirolimus serine/threonine-protein kinase mtor small molecule Successful target TTD , drugbank , DGIDB Perivascular Epithelioid Cell Neoplasms[MeSHID:D054973]
Lymphangioleiomyomatosis[MeSHID:D018192]
Maintenance[MeSHID:D008283]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Uveitis[MeSHID:D014605]		 0.17 approved,investigational inhibitor
sirolimus serine/threonine-protein kinase mtor small molecule Successful target TTD , drugbank , DGIDB Perivascular Epithelioid Cell Neoplasms[MeSHID:D054973]
Lymphangioleiomyomatosis[MeSHID:D018192]
Maintenance[MeSHID:D008283]
Kidney[MeSHID:D007668]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Myeloma[MeSHID:D009101]
Disease[MeSHID:D004194]
Transplanted organ[MeSHID:D019737]		 0.17 approved,investigational inhibitor
click here to return to the previous page